Ad is loading...
ARSMX
Price
$10.94
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
VISVX
Price
$50.61
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

ARSMX vs VISVX

Header iconARSMX vs VISVX Comparison
Open Charts ARSMX vs VISVXBanner chart's image
AMG River Road Small-Mid Cap Value N
Price$10.94
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$50.61
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
ARSMX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ARSMX vs. VISVX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARSMX is a StrongBuy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. ARSMX (340M). VISVX pays higher dividends than ARSMX: VISVX (1.90) vs ARSMX (0.10). ARSMX was incepted earlier than VISVX: ARSMX (18 years) vs VISVX (27 years). ARSMX is a more actively managed with annual turnover of: 30.00 vs. VISVX (16.00). ARSMX has a lower initial minimum investment than VISVX: ARSMX (2000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 30.04 vs. ARSMX (19.36). VISVX return over 5 years is better than : 62.14 vs. ARSMX (32.90).
ARSMXVISVXARSMX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years27 years-
Gain YTD15.25217.71286%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets340M57.6B1%
Annual Yield % from dividends0.101.905%
Returns for 1 year19.3630.0464%
Returns for 3 years5.2216.9231%
Returns for 5 years32.9062.1453%
Returns for 10 years22.15109.8320%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT9.240.20
+2.21%
Enerflex Ltd
RVSN0.440.01
+1.60%
Rail Vision Ltd
CAG27.170.05
+0.18%
Conagra Brands
FULC2.97-0.02
-0.67%
Fulcrum Therapeutics
KYMR43.51-0.54
-1.23%
Kymera Therapeutics